David Schultz
Tracked across 2 events · 18 articles · First seen Jun 02, 2026 · Last active Aug 15, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Tech
A small but growing body of research indicates that GLP-1 drugs, commonly used for obesity and diabetes, may also be effective in treating polyendocrine metabolic ovarian syndrome (PMOS), a hormonal disorder affecting 1 in 8…
Impact: Mother of Charlotte Touzalin, also has PMOS, advocates for her daughter's treatment and is fighting with her insurer to continue GLP-1 coverage.
Aug 15, 2026 · 12 articles
Tech
Impact: David Schultz, Risk Manager for the University of Lethbridge, provided a testimonial highlighting the need for such a solution in municipal security.
Jun 02, 2026 · 6 articles
40
David Schultz fighting insurerGLP-1 drugs show promise for PMOS
ERGEN INTELLIGENCE
Track David Schultz live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard